Efficacy dominated decision drivers, with patients focusing on “how well a drug might work” and physicians emphasizing OS and PFS/time-to-next-treatment as core endpoints. Safety ranked second for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results